Atlas Trials

Managed Access Programs for TQJ230, Pelacarsen

Clinical trial NCT07000695 · AVAILABLE

Trial details

NCT number
NCT07000695
Sponsor
Novartis Pharmaceuticals
Status
AVAILABLE
Study type
EXPANDED_ACCESS
Atherosclerotic Cardiovascular Disease, ASCVD

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.